Insuline Medical (Israel) Performance
| INSL Stock | ILS 230.00 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of -0.62, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Insuline Medical are expected to decrease at a much lower rate. During the bear market, Insuline Medical is likely to outperform the market. At this point, Insuline Medical has a negative expected return of -0.0088%. Please make sure to check out Insuline Medical's total risk alpha, potential upside, kurtosis, as well as the relationship between the value at risk and skewness , to decide if Insuline Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Insuline Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Insuline Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Other Cashflows From Financing Activities | 508 K | |
| Total Cashflows From Investing Activities | -3000.00 |
Insuline |
Insuline Medical Relative Risk vs. Return Landscape
If you would invest 25,200 in Insuline Medical on August 29, 2024 and sell it today you would lose (2,200) from holding Insuline Medical or give up 8.73% of portfolio value over 90 days. Insuline Medical is generating negative expected returns and assumes 6.2173% volatility on return distribution over the 90 days horizon. Simply put, 55% of stocks are less volatile than Insuline, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Insuline Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Insuline Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Insuline Medical, and traders can use it to determine the average amount a Insuline Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0014
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | INSL |
Estimated Market Risk
| 6.22 actual daily | 55 55% of assets are less volatile |
Expected Return
| -0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Insuline Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Insuline Medical by adding Insuline Medical to a well-diversified portfolio.
Insuline Medical Fundamentals Growth
Insuline Stock prices reflect investors' perceptions of the future prospects and financial health of Insuline Medical, and Insuline Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Insuline Stock performance.
| Price To Earning | (40.77) X | |||
| Revenue | 40 K | |||
| EBITDA | (6.82 M) | |||
| Cash And Equivalents | 1.15 M | |||
| Cash Per Share | 2.86 X | |||
| Book Value Per Share | (0.16) X | |||
| Cash Flow From Operations | (7.68 M) | |||
| Earnings Per Share | (30.78) X | |||
| Total Asset | 1.58 M | |||
| Retained Earnings | (158 M) | |||
| Current Asset | 8 M | |||
| Current Liabilities | 9 M | |||
About Insuline Medical Performance
By analyzing Insuline Medical's fundamental ratios, stakeholders can gain valuable insights into Insuline Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Insuline Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Insuline Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Yaad Sihan Projects Management and Entrepreneurship Ltd. is headquartered in Jerusalem, Israel. Insuline Medical is traded on Tel Aviv Stock Exchange in Israel.Things to note about Insuline Medical performance evaluation
Checking the ongoing alerts about Insuline Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Insuline Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Insuline Medical generated a negative expected return over the last 90 days | |
| Insuline Medical has high historical volatility and very poor performance | |
| The company has a current ratio of 0.96, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Insuline Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Insuline Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Insuline Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Insuline to invest in growth at high rates of return. When we think about Insuline Medical's use of debt, we should always consider it together with cash and equity. | |
| Insuline Medical reported the revenue of 40 K. Net Loss for the year was (7.01 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Insuline Medical has accumulated about 1.15 M in cash with (7.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.86. |
- Analyzing Insuline Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Insuline Medical's stock is overvalued or undervalued compared to its peers.
- Examining Insuline Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Insuline Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Insuline Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Insuline Medical's stock. These opinions can provide insight into Insuline Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Insuline Stock analysis
When running Insuline Medical's price analysis, check to measure Insuline Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insuline Medical is operating at the current time. Most of Insuline Medical's value examination focuses on studying past and present price action to predict the probability of Insuline Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insuline Medical's price. Additionally, you may evaluate how the addition of Insuline Medical to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |